1Abrahamson M,Alvarez-Fernandez M,Nathanson C M.Cystatins. Biochemical Society Symposia . 2003
2Lee MJ,Yu GR,Park SH,Cho BH,Ahn JS,Park HJ,et al.Identification of cystatin B as a potential serum marker in hepatocellular carcinoma. Clinical Cancer Research . 2008
3Ko E,Park SE,Cho EY,Kim Y, et al.Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER-4 in invasive breast cancer. Breast Cancer Research . 2010
4Liang Cheng,Shaobo Zhang,Darrell D Davidson,et al.Molecular deter-minants of tumor recurrence in the urinary bladder. Future Oncology . 2009
5F Ponten,JM Schwenk,A Asplund,P-HD Edqvist.The Human Protein Atlas as a proteomic resource for biomarker discovery. Journal of Internal Medicine . 2011
6R Siegel,D Naishadham,A Jemal.Cancer statistics, 2012. CA A Cancer Journal for Clinicians . 2012
7Feldman AS,Banyard J,Wu CL,et al.Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression. Clinical Cancer Research . 2009
8Schmittgen TD,,Livak KJ.Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc . 2008
9Yoneda K,Lida H,Endo H et al.Identification of Cystatin SN asa novel tumor marker for colorectal cancer. International Journal of Oncology . 2009
10Hurst R.Does the biomarker search paradigm need re-booting. BMC Urology . 2009
